Cargando…

Sulindac for stroke treatment: neuroprotective mechanism and therapy

Detalles Bibliográficos
Autores principales:	Modi, Jigar Pravinchandra, Prentice, Howard, Wu, Jang-Yen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316457/ https://www.ncbi.nlm.nih.gov/pubmed/25657710 http://dx.doi.org/10.4103/1673-5374.147919

Ejemplares similares

Mechanisms of Neuronal Protection against Excitotoxicity, Endoplasmic Reticulum Stress, and Mitochondrial Dysfunction in Stroke and Neurodegenerative Diseases
por: Prentice, Howard, et al.
Publicado: (2015)

Neuroprotective Mechanisms of Taurine against Ischemic Stroke
por: Menzie, Janet, et al.
Publicado: (2013)

The Role of NMDA Receptor Partial Antagonist, Carbamathione, as a Therapeutic Agent for Transient Global Ischemia
por: Modi, Jigar Pravinchandra, et al.
Publicado: (2023)

Mode of action of granulocyte-colony stimulating factor (G-CSF) as a novel therapy for stroke in a mouse model
por: Modi, Jigar, et al.
Publicado: (2020)

Molecular mechanisms of NMDA receptor-mediated excitotoxicity: implications for neuroprotective therapeutics for stroke
por: Li, Victor, et al.
Publicado: (2016)

Intranasal insulin neuroprotection in ischemic stroke
por: Lioutas, Vasileios-Arsenios, et al.
Publicado: (2016)

A 3R-Tau-mediated mechanism in oligodendrocytes: could it be the key for neuroprotection after stroke?
por: Villa Gonzalez, Mario, et al.
Publicado: (2021)

Granulocyte-colony stimulating factor gene therapy as a novel therapeutics for stroke in a mouse model
por: Menzie-Suderam, Janet M., et al.
Publicado: (2020)

Inhibition of the AMPK/nNOS pathway for neuroprotection in stroke
por: Khan, Mushfiquddin, et al.
Publicado: (2016)

Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023)

Excitotoxicity-induced endocytosis as a potential target for stroke neuroprotection
por: Díaz-Guerra, Margarita
Publicado: (2020)

Calpain Cleavage of Brain Glutamic Acid Decarboxylase 65 Is Pathological and Impairs GABA Neurotransmission
por: Buddhala, Chandana, et al.
Publicado: (2012)

Immunization with Cop-1 promotes neuroprotection and neurogenesis after ischemic stroke
por: Cruz, Yolanda, et al.
Publicado: (2015)

A Desmoid Tumor Responding to Systemic Therapy With Tamoxifen and Sulindac
por: Choudhury, Hasan, et al.
Publicado: (2023)

Noninvasive Tracking of Gene Transcript and Neuroprotection after Gene Therapy
por: Ren, Jiaqian, et al.
Publicado: (2015)

Mechanisms of retinal neuroprotection of calcium dobesilate: therapeutic implications
por: Simó-Servat, Olga, et al.
Publicado: (2017)

Sulindac Prevents Esophageal Adenocarcinomas Induced by Gastroduodenal Reflux in Rats
por: Kim, Sung Wook, et al.
Publicado: (2007)

Analysis of the Dissolution Mechanism of Drugs into Polymers: The Case of the PVP/Sulindac System
por: Latreche, Mansour, et al.
Publicado: (2023)

Potential New Therapeutic Intervention for Ischemic Stroke
por: Wu, Jang-Yen, et al.
Publicado: (2021)

Neuroprotection by salubrinal treatment in global cerebral ischemia
por: Anuncibay-Soto, Berta, et al.
Publicado: (2016)

Amine Containing Analogs of Sulindac for Cancer Prevention
por: Mathew, Bini, et al.
Publicado: (2018)

Oxazole and thiazole analogs of sulindac for cancer prevention
por: Mathew, Bini, et al.
Publicado: (2018)

Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome
por: Usategui-Martín, Ricardo, et al.
Publicado: (2020)

Diabetic retinopathy: neurovascular disease requiring neuroprotective and regenerative therapies
por: Oshitari, Toshiyuki
Publicado: (2021)

Modification of autophagy-lysosomal pathway as a neuroprotective treatment for spinal cord injury
por: Lipinski, Marta M., et al.
Publicado: (2015)

A role for lipids as agents to alleviate stroke damage: the neuroprotective effect of 2-hydroxy arachidonic acid
por: Ugidos, Irene F., et al.
Publicado: (2017)

Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development
por: Davis, Jennifer S., et al.
Publicado: (2020)

Why and how does light therapy offer neuroprotection in Parkinson's disease?
por: Mitrofanis, John
Publicado: (2017)

Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits
por: Verheul, H M W, et al.
Publicado: (1999)

Neuroprotection induced by NMDA preconditioning as a strategy to understand brain tolerance mechanism
por: Constantino, Leandra C., et al.
Publicado: (2015)

Neuroprotective properties of kavalactones
por: Tzeng, Yew-Min, et al.
Publicado: (2015)

Food, polyphenols and neuroprotection
por: Silva, Rui F.M., et al.
Publicado: (2017)

Mesenchymal stem cell therapy for retinal ganglion cell neuroprotection and axon regeneration
por: Mead, Ben, et al.
Publicado: (2015)

Spinal cord injury: potential neuroprotective therapy based on neural-derived peptides
por: García, Elisa, et al.
Publicado: (2016)

Lead and Neuroprotection by Iron in ADHD
por: Konofal, Eric, et al.
Publicado: (2007)

Neuroprotective effect of antioxidant compounds
por: Skouta, Rachid
Publicado: (2016)

Drugging SUMOylation for neuroprotection and oncotherapy
por: Bernstock, Joshua D., et al.
Publicado: (2018)

Outlook on the neuroprotective effect of estrogen
por: d’Anglemont de Tassigny, Xavier
Publicado: (2017)

The neuroprotective effects of (S)-3,5-dihydroxyphenylglycine preconditioning in middle cerebral artery occluded rats: a perspective as a contrivance for stroke
por: Nik Ramli, Nik Nasihah, et al.
Publicado: (2015)

Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis
por: Ruiz-López, Francisco José, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t0dhcbotgb1sbn99t88775n3qv